# COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry

> **NCT04559009** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 47 (actual)

## Conditions studied

- Covid19
- Amyotrophic Lateral Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04559009
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-15
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04559009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04559009, "COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04559009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*